全文获取类型
收费全文 | 278篇 |
免费 | 14篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 16篇 |
儿科学 | 26篇 |
妇产科学 | 2篇 |
基础医学 | 21篇 |
口腔科学 | 1篇 |
临床医学 | 34篇 |
内科学 | 48篇 |
皮肤病学 | 8篇 |
神经病学 | 9篇 |
特种医学 | 51篇 |
外科学 | 28篇 |
综合类 | 4篇 |
预防医学 | 4篇 |
眼科学 | 3篇 |
药学 | 28篇 |
中国医学 | 1篇 |
肿瘤学 | 9篇 |
出版年
2021年 | 5篇 |
2018年 | 1篇 |
2017年 | 2篇 |
2016年 | 3篇 |
2015年 | 3篇 |
2014年 | 2篇 |
2013年 | 7篇 |
2012年 | 5篇 |
2011年 | 7篇 |
2010年 | 12篇 |
2009年 | 26篇 |
2008年 | 4篇 |
2007年 | 11篇 |
2006年 | 10篇 |
2005年 | 8篇 |
2004年 | 10篇 |
2003年 | 6篇 |
2002年 | 6篇 |
2001年 | 7篇 |
2000年 | 14篇 |
1999年 | 8篇 |
1998年 | 13篇 |
1997年 | 7篇 |
1996年 | 15篇 |
1995年 | 8篇 |
1994年 | 15篇 |
1993年 | 11篇 |
1992年 | 4篇 |
1991年 | 2篇 |
1990年 | 6篇 |
1989年 | 5篇 |
1988年 | 7篇 |
1987年 | 2篇 |
1986年 | 2篇 |
1985年 | 3篇 |
1984年 | 2篇 |
1983年 | 3篇 |
1982年 | 3篇 |
1981年 | 2篇 |
1980年 | 1篇 |
1979年 | 1篇 |
1978年 | 1篇 |
1977年 | 1篇 |
1976年 | 5篇 |
1975年 | 3篇 |
1974年 | 6篇 |
1972年 | 1篇 |
1968年 | 2篇 |
1966年 | 1篇 |
1955年 | 1篇 |
排序方式: 共有293条查询结果,搜索用时 0 毫秒
101.
102.
103.
104.
105.
The authors summarize some most significant results of investigations and works in the field of cosmic medicine performed in military-and-medical institutions of the USSR during preparation of man's first space flights. It is shown that our first program of medical-and-biological support of piloted space flights--the program "Vostok"--was formed and practically realized with undoubted leading role of military-and-medical institutions together with the USSR Academy of sciences. 相似文献
106.
107.
Supraspinal vs spinal sites of the antinociceptive action of the subtype-selective NMDA antagonist ifenprodil 总被引:6,自引:0,他引:6
Chizh BA Reissmüller E Schlütz H Scheede M Haase G Englberger W 《Neuropharmacology》2001,40(2):212-220
The N-methyl-D-aspartate (NMDA) antagonist ifenprodil and several structurally related compounds are highly selective for the NR2B-containing receptor subtype. This selectivity could provide an explanation for the reported difference of the analgesic and side-effect profile of ifenprodil-like compounds from other NMDA antagonists. In this work, we have queried if the ifenprodil-induced antinociception can be attributed to the block of NMDA receptors in the spinal cord. Ifenprodil and some other NMDA antagonists (MK-801, memantine) were tested in a model of inflammatory pain (Randall-Selitto) in rats. The in vivo NMDA antagonism was assessed in anaesthetised rats on responses of spinal dorsal horn (DH) neurones to iontophoretic NMDA and in the model of single motor unit (SMU) wind-up. Ifenprodil, MK-801 and memantine dose-dependently increased nociceptive thresholds in the Randall-Selitto model. Antinociceptive doses of the channel blockers selectively antagonised NMDA responses of DH neurones and inhibited wind-up. In contrast, antinociceptive doses of ifenprodil did not show any NMDA antagonism in electrophysiological tests. Although ifenprodil did not inhibit the SMU responses to noxious stimuli in spinalised rats, it markedly and dose-dependently inhibited nociceptive SMU responses in sham-spinalised rats. These results argue against the spinal cord being the principal site of antinociceptive action of ifenprodil; supraspinal structures seem to be involved in this effect. 相似文献
108.
P2X receptors and nociception. 总被引:35,自引:0,他引:35
The potential importance for nociception of P2X receptors, the ionotropic receptors activated by ATP, is underscored by the variety of pain states in which this endogenous ligand can be released. Several important findings have been made recently indicating that P2X receptors can be involved in pain mechanisms both centrally and in the periphery. The roles of ATP at these two sites and the P2X receptor subtypes involved appear to be different. In the periphery, ATP can be released as a result of tissue injury, visceral distension, or sympathetic activation and can excite nociceptive primary afferents by acting at homomeric P2X(3) or heteromeric P2X(2/3) receptors. Centrally, ATP released from central afferent terminals or second order neurons can modulate neurotransmitter release or postsynaptically activate neurons involved in central nociceptive transmission, with P2X(2), P2X(4), P2X(6), and some other receptors being potentially involved. Evidence from in vivo studies suggests that peripheral ATPergic mechanisms are most important under conditions of acute tissue injury and inflammation whereas the relevance of central mechanisms appears to be more limited. Furthermore, the release of ATP and P2X receptor-mediated afferent activation appear to have been implicated in visceral and neuropathic pain; the importance of the ATPergic component in these states needs to be investigated further. Thus, peripheral P2X receptors, and homomeric P2X(3) and/or heteromeric P2X(2/3) receptors in particular, constitute attractive targets for analgesic drugs. The development of selective antagonists of these receptors, suitable for a systemic in vivo use although apparently difficult, may prove a useful strategy to generate analgesics with a novel mechanism of action. 相似文献
109.
NMDA receptor antagonists as analgesics: focus on the NR2B subtype 总被引:14,自引:0,他引:14
Boris A. Chizh P. Max Headley Thomas M. Tzschentke 《Trends in pharmacological sciences》2001,22(12):636-642
Ifenprodil and a group of related compounds are selective antagonists of NR2B-containing NMDA receptors. These compounds are antinociceptive in a variety of preclinical pain models and have a much lower side-effect profile compared with other NMDA receptor antagonists. It remains unclear whether the improved safety of these compounds is due to their subtype selectivity or to a unique mode of inhibition of the receptor. Human trials have so far confirmed the good tolerability of these subtype-selective NMDA receptor antagonists; however, whether they are as effective as other NMDA receptor antagonists in pain patients remains to be demonstrated. 相似文献
110.